Ustekinumab as induction and maintenance therapy for ulcerative colitis – national extended follow-up and a review of the literature
JD Chetwood(The University of Sydney), Rupert W. Leong(The University of Sydney), Kavitha Subramaniam(Australian National University), Melissa Kermeen(Concord Repatriation General Hospital), Sudarshan Paramsothy(University of Chicago), Gregory Moore(Monash Medical Centre), Suneel Gupta(Canberra Hospital), SJ. Connor(Liverpool Hospital), Yoon‐Kyo An(Mater Hospital), Peter De Cruz(The University of Melbourne)
Cited by 3
Related Papers
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
|Journal of Crohn s and Colitis|2017|425
Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study
|Journal of Crohn s and Colitis|2013|114
Defined microbiota transplant restores Th17/RORγt <sup>+</sup> regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas
|Proceedings of the National Academy of Sciences|2020|107
Ulcerative Colitis and Cytomegalovirus Infection: From A to Z
|Journal of Crohn s and Colitis|2020|102
Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis
|Inflammatory Bowel Diseases|2019|94